Renal Cancer - Results from #5580

Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer August 10, 2016

Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients August 9, 2016

Immunotherapy of advanced renal cell carcinoma: Current and future therapies August 9, 2016

Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms August 9, 2016

First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium August 8, 2016

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma August 8, 2016

Medical treatment of renal cancer: new horizons August 7, 2016

Renal fossa recurrence following nephrectomy for renal cell carcinoma: prognostic features and oncologic outcomes August 7, 2016

A tumor profile in Edwards syndrome (trisomy 18) August 5, 2016

Metastasis therapies for renal cancer August 4, 2016

Role of IL-2 in cancer immunotherapy August 4, 2016

[Cancer genetic screening for patient with multiple renal tumors: What is the current practice for what results?] August 3, 2016

Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features August 2, 2016

Surveillance following surgery for nonmetastatic renal cell carcinoma August 1, 2016

Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact August 1, 2016

Assessment of Efficacy, Safety, and Quality of Life of 124 Patients Treated With Axitinib as Second-Line Therapy for Metastatic Renal-Cell Carcinoma: Experience in Real-World Clinical Practice in Japan August 1, 2016

Contemporary Treatment of Metastatic Renal Cell Carcinoma August 1, 2016

Individualized pazopanib dosing: a prospective feasibility study in cancer patients August 1, 2016

Advances in treatment of metastatic renal cell carcinoma July 31, 2016

Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC July 28, 2016

Page 280 of 456